Total Payments
$2,947
2024 Payments
$1,049
Companies
12
Transactions
70
Medicare Patients
3,140
Medicare Billing
$956,862
Payment Breakdown by Category
Food & Beverage$2,947 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,947 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $543.17 | 13 | $0 (2024) |
| Genentech USA, Inc. | $534.89 | 18 | $0 (2024) |
| Dutch Ophthalmic, USA | $356.29 | 3 | $0 (2021) |
| ABBVIE INC. | $333.34 | 11 | $0 (2024) |
| Alimera Sciences, Inc. | $250.27 | 9 | $0 (2024) |
| Allergan, Inc. | $196.72 | 5 | $0 (2022) |
| Regeneron Pharmaceuticals, Inc. | $182.91 | 3 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $150.51 | 3 | $0 (2023) |
| Genentech, Inc. | $144.72 | 1 | $0 (2024) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $125.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,049 | 30 | Genentech USA, Inc. ($275.28) |
| 2023 | $655.58 | 19 | Genentech USA, Inc. ($259.61) |
| 2022 | $448.00 | 12 | ABBVIE INC. ($197.32) |
| 2021 | $794.68 | 9 | Dutch Ophthalmic, USA ($356.29) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: EYE CARE | ||||||
| 11/01/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: EYE CARE | ||||||
| 10/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $62.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/10/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Food and Beverage | In-kind items and services | $95.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 09/10/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/06/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/12/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/06/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $73.79 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/01/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/25/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $144.72 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/10/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: EYE CARE | ||||||
| 05/16/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/16/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/07/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/29/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 04/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $142.94 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/21/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,809 | 7,281 | $1.7M | $705,153 |
| 2022 | 15 | 1,155 | 1,549 | $915,515 | $231,988 |
| 2021 | 2 | 46 | 53 | $43,709 | $3,884 |
| 2020 | 3 | 130 | 180 | $167,197 | $15,837 |
Total Patients
3,140
Total Services
9,063
Medicare Billing
$956,862
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 94 | 627 | $757,600 | $422,111 | 55.7% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 27 | 3,900 | $214,500 | $110,983 | 51.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 127 | 380 | $283,000 | $38,174 | 13.5% |
| 92134 | Imaging of retina | Office | 2023 | 390 | 811 | $121,650 | $26,719 | 22.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 201 | 234 | $73,100 | $24,206 | 33.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 166 | 312 | $80,580 | $23,483 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 153 | 153 | $65,025 | $19,086 | 29.4% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 70 | 74 | $29,600 | $8,415 | 28.4% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 15 | 22 | $17,100 | $6,032 | 35.3% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 229 | 346 | $17,300 | $4,398 | 25.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $10,350 | $4,330 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 40 | $12,000 | $4,251 | 35.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 126 | 154 | $11,550 | $3,155 | 27.3% |
| 92250 | Photography of the retina | Office | 2023 | 79 | 102 | $20,400 | $3,042 | 14.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $4,225 | $1,995 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 26 | $3,900 | $1,942 | 49.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 22 | 35 | $9,900 | $1,541 | 15.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 11 | 29 | $8,700 | $1,291 | 14.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 44 | 184 | $202,400 | $123,885 | 61.2% |
| 67028 | Injection of drug into eye | Facility | 2022 | 155 | 240 | $220,820 | $19,331 | 8.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 118 | 118 | $54,770 | $15,375 | 28.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 131 | 136 | $88,700 | $14,485 | 16.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 79 | 130 | $91,873 | $13,099 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 111 | $91,860 | $11,216 | 12.2% |
| 92134 | Imaging of retina | Office | 2022 | 172 | 208 | $31,200 | $6,816 | 21.8% |
About Dr. Greg Budoff, MD
Dr. Greg Budoff, MD is a Retina Specialist healthcare provider based in Manchester, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2016. The National Provider Identifier (NPI) number assigned to this provider is 1700239530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greg Budoff, MD has received a total of $2,947 in payments from pharmaceutical and medical device companies, with $1,049 received in 2024. These payments were reported across 70 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,947).
As a Medicare-enrolled provider, Budoff has provided services to 3,140 Medicare beneficiaries, totaling 9,063 services with total Medicare billing of $956,862. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Retina Specialist
- Location Manchester, CT
- Active Since 07/17/2016
- Last Updated 09/01/2022
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1700239530
Products in Payments
- Vabysmo (Drug) $673.88
- OZURDEX (Drug) $390.87
- EYLEA (Biological) $366.10
- EYLEA HD (Biological) $359.98
- EVA Ophthalmic Surgical System (Device) $356.29
- ILUVIEN (Drug) $132.55
- Syfovre (Drug) $125.85
- BEOVU (Drug) $125.00
- YUTIQ (Drug) $117.72
- Constellation (Device) $97.96
- XIPERE (Drug) $31.21
- Lucentis (Biological) $5.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.